DrugRisk Update: Court Asks for Pradaxa Lawsuit Test Cases

Share Article

The DrugRisk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

pradaxa lawsuit
DrugRisk has added a Case Management Order from Judge David Herndon, who is overseeing the litigation, asking that lawyers prepare 16 cases for early discovery and the selection of early trials, or “bellwether” cases.

The drug safety advocates at DrugRisk.com are alerting patients taking the blood thinner Pradaxa of updated legal news on the site. A federal judge overseeing hundreds of lawsuits alleging Pradaxa internal bleeding has asked lawyers to prepare a small number of cases for evidence gathering and early test trials.

The goal of DrugRisk is to improve patient safety by sharing the latest warnings, recalls, studies and legal news related to prescription drugs. Visitors can see if others are experiencing similar side effects and if legal action is under way.

Pradaxa was launched in 2010 to prevent strokes in patients with atrial fibrillation. Experts, however, have disagreed over whether it presents dangerous risks for internal bleeding. The FDA recently advised that Pradaxa is no more dangerous than traditional blood thinner warfarin*.

The Institute for Safe Medication Practices, however, warned that patients suffering Pradaxa bleeding are nearly 5 times as likely to die than those with bleeding from warfarin. They also named anticoagulants like Pradaxa among the most dangerous drugs**.

With over 260 patients so far having filed a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Now, DrugRisk has added a Case Management Order from Judge David Herndon, who is overseeing the litigation, asking that lawyers prepare 16 cases for early discovery and the selection of early trials, or “bellwether” cases***.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits.

For more information on the research, Pradaxa side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
**Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
***ilsd.uscourts.gov/opinions/ilsd_live.3.12.md.2385.2323437.0.pdf#search="pradaxa"

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
DrugRisk
888-415-1859
Email >
Visit website